0800 Immune

0800 466 863

Antigen literature review for the New Zealand National Immunisation Schedule, 2016: Pneumococcal disease: ten-valent pneumococcal conjugate vaccine

This review was conducted to consider the safety of the ten-valent pneumococcal conjugate vaccine (PCV-10; Synflorix®) and its effectiveness in preventing pneumococcal disease, in particular invasive pneumococcal disease (IPD), in target age groups and the wider community when included in the childhood national immunisation schedule. The impact on otitis media incidence and non-invasive pneumococcal infections is also considered. Literature published between January 2013 and November 2016 is evaluated.

The Immunisation Advisory Centre
December 2016
Type of Research 
Menu Category 
Publication Date 
Thursday, December 1, 2016

Last updated: May 2017